期刊文献+

利奈唑胺治疗结核性脑膜炎的效果研究 被引量:7

Effect of Linezolid in Treatment of Tuberculosis Meningitis
下载PDF
导出
摘要 目的研究利奈唑胺对结核性脑膜炎的治疗效果。方法研究2015年1-11月纳入结核性脑膜炎患者共55例,随机分2组。27例选用常规治疗,入对照组;其余28例在该基础上,应用利奈唑胺,入研究组。组间比较。结果两组中研究组脑脊液压力、WBC、蛋白定量、葡萄糖及氯化物等指标改善明显,治疗有效率高,差异具有统计学意义(P〈0.05)。结论利奈唑胺治疗结核性脑膜炎效果佳,有效率高。 Objective Linezolid effect in treatment of tuberculosis meningitis is to be studied. Methods Chose 55 patients of tuberculosis meningitis who were treated in hospital from January 2015 to November 2015 and separated them into two groups at random,27 patients in control group were given conventional treatment,while 28 patients in study group were given linezolid treatment,and then compared treatment effects between two groups. Results Patients' cerebrospinal fluid pressure,WBC,protein quantification,glucose and chloride values were improved more dramatically in study group,there was a differential between two groups and such a differential had statistic value(P〈0.05). Conclusion Linezolid is effective in treatment of tuberculosis meningitis and such an effective treatment is quite worthwhile to be promoted.
作者 白英姝
出处 《中国卫生标准管理》 2016年第5期67-68,共2页 China Health Standard Management
关键词 结核性脑膜炎 利奈唑胺 治疗 Tuberculosis meningitis Linezolid Treatment
  • 相关文献

参考文献5

二级参考文献48

  • 1Tubau F, Fernandez-Roblas R, Linares J, et al. In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods [J].J Antimicrob Chemother, 2001, 47 (5): 675-680.
  • 2Gee T, Ellis R, Marshall G, et al. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses [J]. Antimicrob Agents Chemother, 2001, 45 (6): 1843-1846.
  • 3Betriu C, Redondo M, Boloix A, et al. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci [J]. J Antimicrob Chemother, 2001, 48 (6): 911-913.
  • 4Zurenko GE, Yagi BH, Schaadt RD, et al. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents [J]. Antimicrob Agents Chemother, 1996, 40 (4): 839-845.
  • 5Cynamon MH, Klemens SP, Sharpe CA, et al. Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model [J]. Antimicrob Agents Chemother, 1999, 43 (5) : 1189-1191.
  • 6Condos R, Hadgiangelis N, Leibert E, et al. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis[J]. Chest, 2008, 134 (1): 187-192.
  • 7Yew WW, Chau CH, Wen KH. Linezolid in the treatment of 'difficult' muhidrug-resistant tuberculosis [J]. Int J Tuberc Lung Dis, 2008, 12 (3): 345-346.
  • 8Fortun J, Martin-Davila P, Navas E, et al. Linezolid for the treatment of multidrug-resistant tuberculosis [J]. J Antimicrob Chemother, 2005, 56 (1): 180-185.
  • 9Park IN, Hong SB, Oh YM, et al. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis [J]. J Antimicrob Chemother, 2006, 58 (3) : 701-704.
  • 10Von der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) -a report often cases[J]. J Infec, 2006, 52 (2): 92-96.

共引文献25

同被引文献49

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部